2021 U-CARS Friday, March 19, 2021 - SESSION 1: Impact of Recent Advances and Discoveries in Myocardial Recovery
Chairs: Kirk Knowlton, MD (Intermountain Healthcare) and James C. Fang, MD (U of Utah)
- Muscle biology leading to novel biomarker and therapy: Cardiac bridging integrator 1 (cBIN1) Robin Shaw, MD, PhD, U of Utah/CVRTI
- Impact of new HF meds (SGLT2i, vericiquat and omecamtiv) on (a) cardiac remodeling and (b) patient outcomes. Gerasimos Filippatos, MD, U of Athens, Greece
- Relapse after recovery from HFrEF: risk factors, pharmacological interventions and CRT. John Cleland, MD, University of Glasgow, Scotland, UK
- Using exercise hemodynamics for recovery assessment in patients with LVAD. Van-Khue Ton, MD, PhD, MGH/Harvard
